NeoBiotechnologies antibodies - validated for discovery
When your research depends on reliable antibody performance, validation matters.
NeoBiotechnologies is recognised for its highly validated antibody portfolio, supporting researchers working in oncology, pathology and translational research. Developed with a strong focus on specificity, sensitivity and reproducibility, NeoBiotechnologies antibodies help researchers move forward with confidence.
As part of our Try it. Trust it. campaign and the backed by the Cambridge Bioscience Antibody Promise, we are offering an exclusive 10% discount on NeoBiotechnologies antibodies for a limited time.
Why choose NeoBiotechnologies?
- Validated for discovery: NeoBiotechnologies antibodies are developed and validated to help researchers generate reliable, reproducible results across a range of applications.
- A trusted oncology portfolio: with a strong focus on cancer research and pathology, NeoBiotechnologies provides antibodies targeting clinically relevant biomarkers and emerging research targets.
- High-quality performance: researchers worldwide rely on NeoBiotechnologies antibodies for their specificity, sensitivity and consistent batch-to-batch performance.
- Antibodies. Guaranteed: in the unlikely event that an antibody does not perform as stated in the manufacturer's datasheet, we'll work with you to make it right through replacement, exchange, credit or refund in accordance with the Cambridge Bioscience Antibody Promise.
Terms & Conditions
Take advantage of our NeoBiotechnologies offer - discount automatically applied to products in our web catalogue.
Quote code NEOBIO10 on purchase orders.
- 10% discount applies to list price only.
- Applicable to catalogue NeoBiotechnologies antibodies.
- Cannot be used in conjunction with any other offer or discount.
- Discount cannot be applied retrospectively.
- Promotion valid from 12 October until 31st December 2026.